Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2018

Feb 15, 2018

32853_dirs_2018-02-15_638a7fb3-7fa5-48b0-bb9c-d530cc2f7901.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2018-02-13

Reporting Person: Burbach Gerhard F (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-13 Common Stock A 8597 Acquired 24115 Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. Subject to the Reporting Person's continued service with the Issuer through each applicable vesting date, twenty-five percent (25%) of the shares underlying the Restricted Stock Units shall vest quarterly on the last day of each quarter during 2018. The Reporting Person has deferred settlement of the Restricted Stock Units to occur within the thirty (30) day period immediately following the earlier to occur of (i) the Reporting Person's termination of service with the Issuer; and (ii) a Change of Control (as defined in the Company's 2011 Equity Incentive Plan).

F2: Includes an aggregate of 19,115 vested Restricted Stock Units for which the Reporting Person has deferred settlement as described above.